Cargando…

Combined external pelvic chemoradiotherapy and image-guided adaptive brachytherapy in treatment of advanced cervical carcinoma: experience from a single institution

PURPOSE: External pelvic chemoradiotherapy and image-guided adaptive brachytherapy (IGABT) were studied in advanced cervical carcinomas. Treatment modalities were defined and related to outcomes and side effects. MATERIAL AND METHODS: From a single cancer center, 138 patients with advanced cervical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Möller, Sigrid, Mordhorst, Louise Bohr, Hermansson, Ruth Sanchez, Karlsson, Leif, Granlund, Ulf, Riemarsma, Cecilia, Sorbe, Bengt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690225/ https://www.ncbi.nlm.nih.gov/pubmed/33293975 http://dx.doi.org/10.5114/jcb.2020.98116

Ejemplares similares

Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy
por: Mordhorst, Louise Bohr, et al.
Publicado: (2016)

3D image-based adapted high-dose-rate brachytherapy in cervical cancer with and without interstitial needles: measurement of applicator shift between imaging and dose delivery
por: Karlsson, Leif, et al.
Publicado: (2017)

Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy
por: Kaliff, Malin, et al.
Publicado: (2018)

HPV-negative Tumors in a Swedish Cohort of Cervical Cancer
por: Kaliff, Malin, et al.
Publicado: (2020)

Long term results of PDR brachytherapy for lip cancer
por: Johansson, Bengt, et al.
Publicado: (2011)

Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long-term results from a uniform clinical series
por: Johansson, Bengt, et al.
Publicado: (2011)

External beam radiotherapy with or without californium-252 neutron brachytherapy for treatment of recurrence after definitive chemoradiotherapy
por: Wu, Wen-an, et al.
Publicado: (2020)

Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies
por: Aridgides, Paul, et al.
Publicado: (2016)

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer
por: Olsén, Johan Staby, et al.
Publicado: (2022)

Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma
por: Mangesius, Julian, et al.
Publicado: (2023)

Natural history of recurrences in endometrial carcinoma
por: SORBE, BENGT, et al.
Publicado: (2014)

Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis
por: Wang, Wenhui, et al.
Publicado: (2021)

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center
por: Johansson, Bengt, et al.
Publicado: (2021)

The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer
por: Karlsson, Leif, et al.
Publicado: (2014)

Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma
por: Sorbe, Bengt
Publicado: (2012)

Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer
por: Kadkhodayan, Sima, et al.
Publicado: (2013)

CT-Guided Pelvic Lymph Nodal Brachytherapy
por: Kunogi, Hiroaki, et al.
Publicado: (2021)

Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16-Positive Vaginal and Vulvar Carcinomas
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2014)

Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
por: Seban, Romain-David, et al.
Publicado: (2019)

External Pelvic Measurement
Publicado: (1885)

Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?
por: Qvick, Alvida, et al.
Publicado: (2017)

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2018)

Results from chemoradiotherapy for squamous cell cervical cancer with or without intracavitary brachytherapy
por: Delgado, Diogo, et al.
Publicado: (2019)

Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study
por: Qian, Shen, et al.
Publicado: (2017)

Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009)

Radiotherapy and Brachytherapy : Proceedings of the NATO Advanced Study Institute on Physics of Modern Radiotherapy & Brachytherapy
por: Caner, Alessandra, et al.
Publicado: (2009)

Comparison of radiological spino-pelvic sagittal parameters in skiers and non-athletes
por: Todd, Carl, et al.
Publicado: (2015)

Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy
por: Takenaka, Tadashi, et al.
Publicado: (2023)

Future directions of in vivo dosimetry for external beam radiotherapy and brachytherapy
por: Verhaegen, Frank, et al.
Publicado: (2020)

Erratum to: Comparison of radiological spino-pelvic sagittal parameters in skiers and non-athletes
por: Todd, Carl, et al.
Publicado: (2016)

What pelvic radiation disease symptoms are experienced by patients receiving external beam radiotherapy and a high-dose-rate brachytherapy boost for prostate cancer?
por: Halkett, Georgia K.B., et al.
Publicado: (2017)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Whole genome expression profiling of blood cells in ovarian cancer patients -Prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14 genes
por: Isaksson, Helena S., et al.
Publicado: (2014)

Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study
por: Li, Lei, et al.
Publicado: (2015)

Palliative treatment of pelvic bone tumors using radioiodine ((125)I) brachytherapy
por: Wang, Chongren, et al.
Publicado: (2016)

Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer
por: Chua, Gail Wan Ying, et al.
Publicado: (2017)

Evaluation of dyskerin expression and the Cajal body protein WRAP53β as potential prognostic markers for patients with primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2022)

Californium versus cobalt brachytherapy combined with external-beam radiotherapy for IIB stage cervical cancer: long-term experience of a single institute
por: Janulionis, Ernestas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i05gk2m22lhqdbkojpa8vmrt6l